22nd December 2021 - Categories: Careers
Can you picture yourself working in a dynamic and creative environment in one of the largest sequencing centers in Europe?
30th October 2021 - Categories: Careers
Can you picture yourself working in a dynamic and creative environment in one of the largest sequencing centers in Europe?
25th March 2021 - Categories: Updates
Thank you for bearing with us through the delays you may have faced in your projects with us.
22nd March 2021 - Categories: Updates
NGI is happy to announce that we will now also be offering long-read sequencing technologies in Stockholm, following in the footsteps of our facility in Uppsala. This will be facilitated through a recently acquired PromethION instrument from Oxford Nanopore Technologies.
4th December 2020 - Categories: Updates
NGI is now offering sequencing using Illumina’s v1.5 NovaSeq Chemistry.
5th November 2020 - Categories: Updates
The last day to submit samples before the holidays is Dec 18th 2020. Please note that you need to have a valid and signed agreement for your project to submit samples. For orders submitted before Dec 14th 2020 we will do our best to prepare a quote in time for you to submit samples before […]
5th November 2020 - Categories: Updates
In wake of the current health and safety requirements for our staff, we may face occasional delays in processing projects and ask you to bear with us during this time. Some of our key personnel – the people behind the NGI – have been ill or functioning as caregivers for those who are. However, we remain committed to […]
7th July 2020 - Categories: Careers
Would you like to work in a dynamic and creative environment in one of the largest sequencing centres in Europe?
1st July 2020 - Categories: Updates
NGI has recently acquired the latest NextSeq 2000 instrument from Illumina. It is currently being installed at the Stockholm site and will shortly be available for our users.
18th May 2020 - Categories: Updates
As a part of the EASI Genomics network NGI will provide services for this COVID-19 call. Apply now!